Skip to content
OBN white logo.

Catalysing Success in Life Sciences

OBN is a not-for-profit membership network that catalyses growth for the life sciences industry. Whether you’re an emerging entrepreneur, R&D SME, investor, analyst, pharma company, science park, TTO or technology / professional services organisation, we are here to give you opportunities to meet, learn, and grow. Read more about how we can help you to:

Create Connections Secure Investment Save Time & Money Join OBN
Patron
IPSEN company logo
Sponsors
BDO logo
Bruntwood SciTech logo
Fisher Scientific logo
Milton Park logo
Parners& logo
Penningtons Manches Cooper Logo
Precision for Medicine logo
Syneos Health logo
ThermoFisher Scientific logo
EBD Group Logo
Venner Shipley Company Logo
Oxford Product Design
Zyme Communications Company Logo

Join us at the next OBN event

Make connections and keep up to date with the latest life sciences industry innovations. View upcoming OBN and Member events.

We pride ourselves on supporting our members to catalyse their success.

We do this by keeping the life sciences community connected and informed, making us an essential partner.

But don’t take our word for it, here is what our members and partners say.

“At Oxford Endovascular we feel that OBN’s well informed team is really invested in our journey, supporting us as the business develops.”

Mike Karim Oxford Endovascular , CEO
Oxford Endovascular Logo

“Through OBN we can make valuable connections with potential customers, keeping them informed about Biosynth’s products and services. Other advantages to being an OBN member include discounted rates for events and conference attendance.”

Adrian Hery Barranco Biosynth, Marketing & Business Development Officer
Biosynth Logo

“I’ve met a number of amazing people through OBN, who are all so open to sharing their experience and helping to support emerging biotechs. I’d encourage everyone to join in, whether a seasoned industry insider, an emerging biotech with exciting science, or a sponsor aiming to build their brand and support new biotech – OBN is great!”

Nick Pumphrey Etcembly, CSO
Etcembly Logo

Latest News

General

Coulter Partners continues partnership with iOnctura and places new Chief Financial Officer

Read More
General
High purity exosome standards enhance research reproducibility
General
Upperton Pharma Solutions Wins Business Expansion Award at the 2025 Pharmaceutical Technology E…
General
The BioEscalator publishes its Portfolio 2025 – a guide for potential partners & investors
General
Coulter Partners Secures Chief Scientific Officer for Biomia
More articles this way